KZIA — Kazia Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $0.10m
- -$0.44m
- AU$0.11m
- 16
- 30
- 80
- 36
Annual cashflow statement for Kazia Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 1.02 | 0.025 | 0.023 | -9.58 | -13.3 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.11 | -22.8 | -15.2 | -9.58 | -13.3 |
| Other Investing Cash Flow Items | 0 | -2.36 | 0 | 0 | — |
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -2.36 | 0 | 0 | — |
| Financing Cash Flow Items | — | — | — | — | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28.1 | 3.73 | 13 | 5.99 | 16 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 18.8 | -20.2 | -2.12 | -3.58 | 2.69 |